Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 10Neoplasms 6Prostatic Neoplasms 5Anxiety Disorders 5Leukemia 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma 3Fatigue 3Depression 3Colorectal Neoplasms 3Rectal Neoplasms 2Primary Myelofibrosis 2Hodgkin Disease 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Stromal Tumors 2Gastrointestinal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Anus Neoplasms 2cyclopia sequence 1Vulvar Neoplasms 1Vomiting 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1

Interventions

Surveys and Questionnaires 1Proflavine 1Oxycodone 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Malignant Neoplasms of Female Genital Organs × Surveys and Questionnaires × Clear all
NCT02740114 2021-10-18

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Terminated
105 enrolled 9 charts
GynecologicOther neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡